Plandai Biotechnology, Inc. Announces Favorable Results of Lycopene Study Using Proprietary Technology

7 February 2012, 5:30 am

SEATTLE, WA-- - Plandaí Biotechnology, Inc. Chief Executive Officer, Roger Duffield, today announced the results of using the Plandaí proprietary method for increasing bioavailability in carotenoids. According ...... Read More »

More Topics from "News"

• Slalom Consulting and Scribe Form Strategic Partnership for Data Migration and Integration
• Oncothyreon Announces Presentations at Upcoming Investment Conferences in February 2012
• Skytap Helps Power Orasi's New Application Performance Testing Solution in the Cloud With HP
• Mariners sign Camp, Kuo
• 451 Research Recognizes Apptio as "Bellwether" Company in IT Financial Management Space
• ClearPoint Alliance with Consulate General of Mexico in Seattle Furthers Financial Education in Hispanic Community
• Bring Your "Perfect Catch" to Ivar's for Valentine's Day and Enjoy Waterfront Views, Special Romantic Menu
• Stratos Product Development Lends Critical Design Expertise to Mimic Technologies' dV-Trainer Surgical Training Device
• PetroCard Announces David Harris as New Chief Executive Officer